- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medigene AG (MDG1k)
Medigene AG stock price live, this page displays ETR MDG1k stock exchange data. View the MDG1k premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medigene AG real time stock price chart below.
What Is the Medigene AG Stock Price Today?
The Medigene AG stock price today is 0.185.
What Is the Stock Symbol for Medigene AG?
The stock symbol for Medigene AG is "MDG1k."
What Stock Exchange Does Medigene AG Trade On?
Medigene AG is listed and trades on the Xetra stock exchange.
Is Medigene AG a Good Stock to Buy?
Determining whether Medigene AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDG1k quote. (ISIN: DE000A40ESG2)
What Is the Medigene AG Stock Price Today?
The Medigene AG stock price today is 0.185.
What Is the Stock Symbol for Medigene AG?
The stock symbol for Medigene AG is "MDG1k."
What Stock Exchange Does Medigene AG Trade On?
Medigene AG is listed and trades on the Xetra stock exchange.
Is Medigene AG a Good Stock to Buy?
Determining whether Medigene AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDG1k quote. (ISIN: DE000A40ESG2)
0.185
+0.016(+9.50%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.150
0.185
52 wk Range
0.110
3.230
MDG1k Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1500.185
52 wk Range
0.1103.230
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MDG1k Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.800
Upside
+1,954.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Medigene AG Company Profile
Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company’s end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its lead product includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications. The company also develops MDG2011, MDG2021, MDG2012, MDG20XX, and MDG10xx to treat multiple solid tumors. It has a strategic partnership with BioNTech to develop TCRbased immunotherapies against cancer; and 2seventy bio, Inc. for the development of TCR immunotherapies, as well as a collaboration agreement with National Cancer Institute to evaluate the potential of T cell receptors to be used in new cell constructs for the treatment of solid tumors. It has operations in Germany, the United States, and Asia. The company has a research collaboration agreement with WuXi Biologics to design and co-research TCR-guided T Cell engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors; and strategic co-development agreement with EpimAb Biotherapeutics, Inc. to research and develop off-the-shelf TCR-guided T Cell Engagers for the treatment of immune-related disorders, such as solid tumors. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.
Compare MDG1k to Peers and Sector
Metrics to compare | MDG1k | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMDG1kPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −0.7x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.1x | 0.5x | 2.6x | |
Price / LTM Sales | 0.3x | 6.6x | 2.9x | |
Upside (Analyst Target) | - | 601.1% | 57.1% | |
Fair Value Upside | Unlock | 42.6% | 9.0% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.800
(+1,954.05% Upside)
Earnings
Latest Release
Mar 26, 2025
EPS / Forecast
-0.30 / -0.38
Revenue / Forecast
6.52M / 6.52M
FAQ
What Is the Medigene (MDG1k) Stock Price Today?
The Medigene stock price today is 0.19
What Stock Exchange Does Medigene Trade On?
Medigene is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Medigene?
The stock symbol for Medigene is "MDG1k."
What Is the Medigene Market Cap?
As of today, Medigene market cap is 2.28M.
What is Medigene Earnings Per Share?
The Medigene EPS is -1.26.
What Is the Next Medigene Earnings Date?
Medigene will release its next earnings report on 13 May 2025.
From a Technical Analysis Perspective, Is MDG1k a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.